20.40
+0.10
+(0.49%)
At close: April 17 at 5:31:31 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,017,045
1,017,045
969,462
930,969
1,726,503
Cost of Revenue
800,502
800,502
766,114
770,818
1,466,457
Gross Profit
216,543
216,543
203,348
160,151
260,046
Operating Expense
320,766
320,766
285,915
311,011
455,573
Operating Income
-104,223
-104,223
-82,567
-150,860
-195,527
Net Non Operating Interest Income Expense
-17,577
-17,577
-16,919
-18,236
-16,905
Pretax Income
-102,758
-102,758
-118,656
-169,116
-226,684
Tax Provision
-5,505
-5,505
-1,091
1,996
-949
Net Income Common Stockholders
-97,253
-97,253
82,280
-171,115
-225,735
Diluted NI Available to Com Stockholders
-97,253
-97,253
82,280
-171,115
-225,735
Basic EPS
-8.25
--
7.05
-15.88
-23.40
Diluted EPS
-8.25
--
7.05
-15.88
-23.40
Basic Average Shares
11,792.55
--
11,673.66
10,775.22
9,645.38
Diluted Average Shares
11,792.55
--
11,673.66
10,775.22
9,645.38
Rent Expense Supplemental
--
--
--
6,890
4,884
Total Expenses
1,121,268
1,121,268
1,052,029
1,081,829
1,922,030
Net Income from Continuing & Discontinued Operation
-97,253
-97,253
82,280
-171,115
-225,735
Normalized Income
-110,290.04
-110,290.04
-121,944.36
-181,596.99
-224,027.18
Interest Income
2,380
2,380
3,023
365
533
Interest Expense
19,541
19,541
19,138
17,535
16,186
Net Interest Income
-17,577
-17,577
-16,919
-18,236
-16,905
EBIT
-83,217
-83,217
-99,518
-151,581
-210,498
EBITDA
-37,638
-37,638
-56,082
-111,940
-159,355
Reconciled Cost of Revenue
800,502
800,502
766,114
770,818
1,466,457
Reconciled Depreciation
45,579
45,579
43,436
39,641
51,143
Net Income from Continuing Operation Net Minority Interest
-97,253
-97,253
-117,565
-171,112
-225,735
Total Unusual Items Excluding Goodwill
13,775
13,775
4,420
11,459
-1,715
Total Unusual Items
13,775
13,775
4,420
11,459
-1,715
Normalized EBITDA
-51,413
-51,413
-60,502
-123,399
-157,640
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
737.96
737.96
40.64
974.02
-7.18
12/31/2021 - 7/6/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RDC.DE Redcare Pharmacy NV
126.50
+1.28%
SHOP.VI Redcare Pharmacy NV
126.00
+0.32%
TALEA.MI Talea Group S.p.A.
4.6000
+2.00%
SAEYY Redcare Pharmacy NV
12.83
0.00%
FRAGUAB.MX Corporativo Fragua, S.A.B. de C.V.
523.00
-1.32%
APOTEA.ST Apotea AB
72.71
-0.57%
7731.TWO MARX Biotech Co., Ltd.
6.08
-1.46%
0241.HK ALI HEALTH
4.570
+1.33%
4175.TWO MedFirst Healthcare Services, Inc.
63.70
+1.92%
HITI High Tide Inc.
2.3100
+3.59%